PWC will replace KPMG as auditors of AstraZeneca, after the FTSE 100 pharmaceuticals company changed the firm that vets its accounts for the first time since the merger of Astra and Zeneca in 1999.
AstraZeneca said PwC will act as its external auditor for the financial year ending 31 December 2017, pending shareholder approval. KPMG, which earned £10m for its audit and audit-related work in 2014/15, will continue as auditors for 2016.
The company had previously said the audit would be put out to tender by 2018 in accordance with the transitional guidance issued by the Financial Reporting Council.
“The proposed change of auditor follows a recommendation by the audit committee to the board based on a formal tender in line with best practice,” AstraZeneca said.
Further information on the tender process will be provided AstraZeneca’s next annual report, due in March.
Under the deal, Blick Rothernberg will sit within HgCapital’s Services sector but will retain its name and way of doing business
Despite concerns over the viability of BHS, advisers including Grant Thornton were paid in the millions of pounds for their roles, according to the Work and Pensions and Business, Innovation and Skills Select Committees
Colin ponders how the Pokemon craze is permeating the world of accountancy
The UK’s decision to leave the EU has raised questions about whether the FRC's regulatory framework should change in the future